We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
No fiscal-year history available for this company yet.
No P/E, the company is not profitable on a trailing basis.
DongBang Medical Co., Ltd., established in 1985 and headquartered in Seongnam-si, South Korea, is a prominent manufacturer and distributor specializing in a wide array of medical devices, bio medical solutions, cosmetic devices, and aesthetic fillers. The company's product portfolio includes hyaluronic acid (HA) fillers, marketed under brand names such as ELASTY GRAND, ELASTY DEEP PLUS, and ELASTY G PLUS, which are utilized for facial wrinkle improvement and volume restoration. They also offer various aesthetic threads, including ELASTY LINE, ELASTY MESHFILL, and ELASTY-V BARB, alongside essential medical consumables like cannulas, needles, and syringes. Beyond medical aesthetics, DongBang Medical provides an extensive range of skincare and haircare products. This includes moisturizing masks (Hyaluronic acid, Beta-Glucan), the FILL US patch, and specialized lines such as AG Solution (calming, defying, regenerating), AT Solution (cleansing, moisturizing, concentrated), AC Solution (clarifying, refining), and Hair Solution (shampoo, treatment, tonic), complemented by HA ESSENCE. Furthermore, their offerings extend to traditional healthcare items like hand acupuncture devices (e.g., hand acupuncture, spring hand acupuncture tube) and various other general goods such as pillows, charcoal, heat-resistant silicone, and cupping tools. DongBang Medical has a significant international presence, exporting its products to approximately 50 countries across North America, South America, Europe, Asia, and the Middle East.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 240550.KQ and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
